Research programme: HIV RNase H inhibitors - Roche

Drug Profile

Research programme: HIV RNase H inhibitors - Roche

Alternative Names: R-0335; R-1206

Latest Information Update: 20 Aug 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Small molecules
  • Mechanism of Action RNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 11 Jul 2008 Discontinued - Preclinical for HIV infections in United Kingdom (PO)
  • 04 Sep 2007 Preclinical data presented at the 234th American Chemical Society National Meeting (234th-ACS-2007)
  • 01 Jun 2004 Preclinical trials in HIV infections treatment in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top